Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →15
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,660
Total Claims
$1.2M
Drug Cost
651
Beneficiaries
$1,870
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-51%
Opioid rate vs peers
1.1% vs 2.2% avg
+32%
Cost per patient vs peers
$1,870 vs $1,411 avg
+33%
Brand preference vs peers
14.1% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.1%
Opioid Rate
107
Opioid Claims
$1,550
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,358 claims · $1.0M
Generic: 8,243 claims · $208K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 158 | $227K |
| Dulaglutide | 110 | $162K |
| Empagliflozin | 100 | $89K |
| Rivaroxaban | 60 | $65K |
| Mirabegron | 70 | $53K |
| Linagliptin | 42 | $49K |
| Semaglutide | 37 | $49K |
| Insulin Glargine,hum.Rec.Anlog | 46 | $34K |
| Budesonide/Formoterol Fumarate | 29 | $24K |
| Insulin Lispro | 14 | $22K |
| Fluticasone/Umeclidin/Vilanter | 16 | $19K |
| Dapagliflozin Propanediol | 15 | $16K |
| Fluticasone/Vilanterol | 12 | $13K |
| Rosuvastatin Calcium | 604 | $13K |
| Atorvastatin Calcium | 663 | $13K |
Prescribing Profile
Patient Profile
77
Avg Age
53%
Female
1.33
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About